Form 4: Organon & Co. Executive Susanne Fiedler Reports Acquisition of Restricted Stock Units and Stock Options

Chief Commercial Officer Susanne Fiedler reports the acquisition of restricted stock units and stock options in Organon & Co.

Summary

• Susanne Fiedler, Chief Commercial Officer of Organon & Co., filed a Form 4 with the SEC.
• The report details the acquisition of 29,255 restricted stock units (RSUs) and 119,825 stock options on March 29, 2024.
• The RSUs represent a contingent right to receive one share of Organon common stock for each RSU.
• The RSUs vest in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
• The stock options have an exercise price of $18.8 and also vest in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, suggesting stability and alignment of interests. The sentiment is neutral to positive as it indicates confidence in the company's future.

Positives

• The acquisition of RSUs and stock options by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs and stock options indicates a long-term commitment by the executive to the company's success.

Industry Context

Stock option and RSU grants are a common practice in the pharmaceutical industry to incentivize and retain key executives.

Comparison to Industry Standards

• Comparing Organon's executive compensation structure to peers like Viatris or Teva Pharmaceutical Industries would provide a benchmark for assessing the competitiveness of their equity grants.
• Industry standards for vesting schedules typically range from 3 to 5 years, aligning with Organon's 3-year vesting period.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align executive interests with long-term shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates